DRUG SAFETY IN PORPHYRIA: RISKS OF VALPROATE AND METOCLOPRAMIDE
- 11 July 1981
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 318 (8237) , 91
- https://doi.org/10.1016/s0140-6736(81)90440-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The “glucose effect” in acute hepatic porphyrias and in experimental porphyriaJournal of Molecular Medicine, 1981
- International review of drugs in acute porphyria—1980International Journal of Biochemistry, 1980
- DRUG SAFETY IN PORPHYRIAThe Lancet, 1980
- DRUG SAFETY IN PORPHYRIAThe Lancet, 1980
- DRUG SAFETY IN PORPHYRIAThe Lancet, 1980
- Seizure management in acute hepatic porphyriaNeurology, 1980
- Drug Interactions in Experimental Hepatic PorphyriaEnzyme, 1973
- The Induction in Vitro of the Synthesis of δ-Aminolevulinic Acid Synthetase in Chemical Porphyria: A Response to Certain Drugs, Sex Hormones, and Foreign ChemicalsPublished by Elsevier ,1966